Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Alecensa (alectinib)
.
Show all posts
Showing posts with label
Alecensa (alectinib)
.
Show all posts
Monday, December 4, 2017
FDA Approves Alecensa (alectinib) as First-Line Treatment for ALK-Positive Metastatic Non-Small Cell Lung Cancer
›
Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Appl...
Tuesday, March 15, 2016
FDA Approves Alecensa (alectinib) for ALK-Positive Non-Small Cell Lung Cancer
›
The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-...
Tuesday, February 9, 2016
Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC
›
The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-smal...
›
Home
View web version
